Petmed Express Stock Price To Earning
| PQM Stock | EUR 4.20 0.17 3.89% |
PetMed Express fundamentals help investors to digest information that contributes to PetMed Express' financial success or failures. It also enables traders to predict the movement of PetMed Stock. The fundamental analysis module provides a way to measure PetMed Express' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PetMed Express stock.
PetMed |
PetMed Express Company Price To Earning Analysis
PetMed Express' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current PetMed Express Price To Earning | 9.60 X |
Most of PetMed Express' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PetMed Express is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, PetMed Express has a Price To Earning of 9.6 times. This is 54.22% lower than that of the Consumer Defensive sector and 28.41% lower than that of the Pharmaceutical Retailers industry. The price to earning for all Germany stocks is 66.57% higher than that of the company.
PetMed Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PetMed Express' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PetMed Express could also be used in its relative valuation, which is a method of valuing PetMed Express by comparing valuation metrics of similar companies.PetMed Express is currently under evaluation in price to earning category among its peers.
PetMed Fundamentals
| Return On Equity | 0.0831 | |||
| Return On Asset | 0.0524 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 290.33 M | |||
| Shares Outstanding | 21.08 M | |||
| Shares Owned By Insiders | 4.29 % | |||
| Shares Owned By Institutions | 82.51 % | |||
| Price To Earning | 9.60 X | |||
| Price To Book | 2.78 X | |||
| Price To Sales | 1.44 X | |||
| Revenue | 273.42 M | |||
| Gross Profit | 78.08 M | |||
| EBITDA | 28.45 M | |||
| Net Income | 21.1 M | |||
| Cash And Equivalents | 100.53 M | |||
| Cash Per Share | 4.91 X | |||
| Current Ratio | 6.79 X | |||
| Book Value Per Share | 6.57 X | |||
| Cash Flow From Operations | 18.5 M | |||
| Earnings Per Share | 0.53 X | |||
| Target Price | 32.0 | |||
| Number Of Employees | 212 | |||
| Beta | 0.65 | |||
| Market Capitalization | 367.6 M | |||
| Total Asset | 176.32 M | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.06 % | |||
| Five Year Return | 3.28 % | |||
| Net Asset | 176.32 M | |||
| Last Dividend Paid | 1.2 |
About PetMed Express Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PetMed Express's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PetMed Express using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PetMed Express based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PetMed Stock
When determining whether PetMed Express is a strong investment it is important to analyze PetMed Express' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PetMed Express' future performance. For an informed investment choice regarding PetMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in PetMed Stock please use our How to Invest in PetMed Express guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.